In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
For more than a decade, ticagrelor (Brilinta in the US and Brilique in…
In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
For more than a decade, ticagrelor (Brilinta in the US and Brilique in…
Prevention and treatment campaigns are not adequately targeting the particular needs of the 50+ years age group.
Indeed, between 2000 and 2016, the number of adults aged 50 years and older living with HIV in sub-Saharan Africa doubled. At…
Researchers from Tokyo Metropolitan University have created a new way of telling “aged” human cells apart from younger ones using electric fields. While key markers have been found for these “senescent” cells, current methods require biochemical…
New research that used blood markers to measure linoleic acid levels and their relation to cardiometabolic risk adds evidence that this omega-6 fatty acid may help to lower risks for heart disease and type 2 diabetes. The findings challenge…
Zack Wickham (L), seen here with Melissa Marie Carelli and Benji Quach, got injections of “Scrotox” … More
You…
Scientists at the USC Leonard Davis School of Gerontology have discovered a key connection between high levels of iron in the brain and increased cell damage in people who have both Down syndrome and Alzheimer’s disease.
In the study, researchers…
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at the European Academy of Neurology (EAN) Congress 2025.1
Researchers at the Headache Center of the…
TOPSHOT – US President Joe Biden looks on as he participates in the first presidential debate of the … More
The nation’s biggest health insurance companies are poised to ease prior authorization, the process … More
Tiny, newly formed tumors shed small fragments of DNA that are swept into the bloodstream. Future cancer screening tests could detect them early.